Curated News
By: NewsRamp Editorial Staff
April 22, 2025
Kamada Expands Hyper-Immune Plasma Collection with New Facility in San Antonio
TLDR
- Kamada Ltd. is expanding its specialty hyper-immune plasma collection, positioning itself as a leader in the field.
- Kamada extracts antibodies from human donors to create hyper-immune plasma, used to reduce infection risk and disease severity.
- Kamada's plasma collection centers save lives by providing specialty plasma therapeutics to treat rare and underserved conditions.
- Kamada's new plasma collection center in San Antonio, Texas, will contribute to fighting infections and preventing diseases with specialty plasma products.
Impact - Why it Matters
This news matters as Kamada's efforts to expand its plasma collection capabilities will not only meet the increasing demand for hyper-immune plasma products but also potentially lower raw material costs. By developing its own plasma collection centers, Kamada aims to reduce dependency on third-party suppliers, improve cost efficiency, and position itself as a key player in the specialty plasma-derived therapeutics field.
Summary
Kamada Ltd., a global biopharmaceutical company, is expanding its specialty hyper-immune plasma collection with the opening of a new plasma collection center in San Antonio, Texas. This facility will support as many as 50 donor beds and is projected to collect up to 50,000 liters annually, adding to Kamada's supply of specialty plasma products. The company aims to receive approvals from the FDA and EMA within nine to twelve months of submitting applications.
Source Statement
This curated news summary relied on this press release disributed by NewMediaWire. Read the source press release here, Kamada Expands Hyper-Immune Plasma Collection with New Facility in San Antonio
